Abbeha Talib: Balancing Stroke Prevention and Bleeding Risk After Successful AF Ablation
Abbeha Talib, Social Media Manager and Content Strategist at Medify HELP, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cardiology in Review, adding:
“Excited to share that our latest work has been published in Cardiology in Review:
‘Discontinuation of Oral Anticoagulants After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.’
What we explored:
In this large-scale analysis, we examined whether oral anticoagulation (OAC) can be safely discontinued after successful catheter ablation for atrial fibrillation (AF), comparing long-term outcomes of OAC discontinuation (OFF-OAC) versus continuation (ON-OAC).
Key findings: (29 studies, 153,352 participants):
- No significant difference in thromboembolic risk with OAC discontinuation (OR: 0.91; P = 0.60)
- OFF-OAC significantly reduced major bleeding risk by approximately 66 percent (OR: 0.34; P less than 0.00001)
- No significant difference in all-cause mortality (OR: 0.67; P = 0.06)
- OAC discontinuation was associated with significantly lower AF recurrence (OR: 0.57; P = 0.0003)
Subgroup insights:
- Greater bleeding reduction with OAC discontinuation was observed in:
- Warfarin users (OR: 0.13) versus warfarin/NOAC users (OR: 0.43)
- Non-Asian cohorts (OR: 0.12) versus Asian cohorts (OR: 0.45)
- Patients switched to antiplatelet therapy (OR: 0.18) versus those not switched (OR: 0.44)
Takeaway:
Discontinuing OAC after successful AF ablation significantly reduces major bleeding without increasing thromboembolic or mortality risk in appropriately selected patients.
OAC may be safely withdrawn in low-risk patients (CHA₂DS₂-VASc less than 2) with careful monitoring, while high-risk patients warrant individualized decision-making.
Grateful to my coauthors Muhammad Tahir, Muhammad Abdullah Naveed, Muhammad Hamza Khan, Muhammad Shaheer Hussain Qureshi, Susheeta Rani, Abdur Rafay Bilal, Muhammad Salik Khan, Shaheer Bin Shafiq, Ali A. Mithani, Saad Ahmed Waqas and mentors for their collaboration on this project.”
Title: Discontinuation of Oral Anticoagulants After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis
Authors: Tahir Muhammad, Naveed Muhammad Abdullah, Khan Muhammad Hamza, Qureshi Shaheer, Rani Susheeta, Bilal Abdur Rafay, Talib Abbeha, Uddin Muhammad Salik, Bin Shafiq Shaheer, Mithani, Ali A., Waqas Saad Ahmed
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH